key: cord-0284984-ftanlso2
authors: Jain, N. L.; Parekh, K.; Saigal, R.; Alyusuf, A.; Kelly, G.; Jha, A.
title: Meta-analysis of COVID-19 patients to understand the key predictors of mortality in the non-vaccinated groups in remote settings
date: 2022-01-05
journal: nan
DOI: 10.1101/2022.01.04.21267659
sha: 8f072be8719760d897292a45b5f290c38fa07236
doc_id: 284984
cord_uid: ftanlso2

Various studies have looked into the impact of the COVID-19 vaccine on large populations. However, very few studies have looked into the remote setting of hospitals where vaccination is challenging due to social structure, myths, and misconceptions. There is a consensus that elevated inflammatory markers such as CRP, ferritin, D-dimer correlate with increased severity of COVID-19 and are associated with worse outcomes. In the present study, through retrospective meta-analysis, we have looked into ~20 months of SARS-COV2 infected patients with known mortality status and identified predictors of mortality concerning their comorbidities, various clinical parameters, inflammatory markers, superimposed infections, length of hospitalization, length of mechanical ventilation and ICU stay. Studies with larger sample sizes have covered the outcomes through epidemiological, social, and survey-based analysis; however, most studies cover larger cohorts from tertiary medical centers. In the present study, we assessed the outcome of non-vaccinated COVID 19 patients in a remote setting for 20 months from January 1, 2020, to August 30, 2021, at CHI Mercy Health in Roseburg, Oregon. We also included two vaccinated patients from September 2021 to add to the power of our cohort. The study will provide a comprehensive methodology and deep insight into multi-dimensional data in the unvaccinated group, translational biomarkers of mortality, and state-of-art to conduct such studies in various remote hospitals.

Abstract: Various studies have looked into the impact of the COVID-19 vaccine on large 26 populations. However, very few studies have looked into the remote setting of hospitals 27 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint Introduction 45 The disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 46 known as coronavirus disease 2019 (COVID-19), has been classified as a pandemic by 47 remote medical centers in guiding management decisions. In this vein, we have decided 77 to conduct this unique study by performing a descriptive meta-analysis in a remote 78 hospital situated in Roseburg, Oregon. The primary purpose of the current research is to 79 develop a formal statistical model to compare the independent associations of any 80 differences in descriptive and clinical data with fatal COVID-19 outcomes stratified 81 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint based on the vaccination status. Having such a study conducted in a remote setting 82 hospital will be a beacon of hope for other similar studies and observations in other 83 remote hospitals within the United States and around the world. 84 To achieve this, we have developed a mathematical model to identify the severity and October 29th, 2021, the state epidemiological data suggested that only 49% of Douglas 105 county's population has been vaccinated. Low rate of vaccination added a lot more to the 106 emotional, social, and personalized health burden on the medical fraternity by in-patient 107 hospitalization flow due to low vaccination rate, which led the resources under severe 108 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint strain 5 . Various studies also looked into the retrospective data to understand the clinical 109 and social biomarkers to educate the community regarding better planning and 110 management of the disease. Various published studies have helped build models based on 111 identifying risk factors to predict severity and mortality and assist the hospitals in better 112 preparing for the COVID-19 surge. Thus, the proposed study intended to review the 113 medical records of deceased COVID-19 patients in our medical center to understand the 114 disease progression during their respective hospital courses. showed moderate bilateral infiltrates, and labs revealed elevated LDH and lymphopenia.

The above examples of unvaccinated and vaccinated patients (one each) show the 135 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. predictors of mortality more precisely in the unvaccinated group. One such critical 145 marker is D-dimer, one of the fragments produced during the degradation of blood clots 146 and is known to be elevated in patients with moderate to severe COVID-19. The 

Despite the plethora of research another critical aspect that remains warranted and 156 requires more accumulation of clinical findings is the need for supplemental oxygenation 157 in COVID-19 patients; higher the need for supplemental oxygen, the higher the risk for 158 severe COVID-19 and death. This will guide the initial placement of the patient 159 appropriately among intensive care unit, step down unit/progressive care unit, medical 160 floors and monitor them closely for decompensation 10 . 161 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint

The primary model will be a logistic regression with the outcome variable being the 189 composite endpoint of severe COVID-19. Multiple imputations will be performed on 190 missing variables. For the secondary analysis of mortality, logistic regression based on 191 30-day mortality will be served. The goodness of fit of the models will be assessed by 192 Harrell's C-statistic with a 95% confidence interval determined by the method of 193 DeLong. Variance inflation factors will be computed for every predictor in the model. 194 We plan to conduct sensitivity analyses restricting the primary research to patients with composite endpoint (severe illness requiring hospitalization). The exact process for the 197 preceding model will be conducted for the sensitivity analyses. All analyses will be 198 performed using R v3.6.3, packages "rms", "Hmisc", "rpart", and "train." (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. Table 1 and Table 2 . We have used m=5, maxit=50, meth='pmm', seed=500 to calculate the missing value in 233 mice function. As shown in (Figure S2 Table S2 ). 236 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. Using the R packages "epitools" and "gtsummary," Table 1, Table 2 , and Table S1 are 249 generated to show patient demographics and a logistic regression equation to evaluate the 250 variables contributing to mortality assess unvaccinated patients.

Charlson Comorbidity Index (CCI) 252 We calculated the Charlson Comorbidity Index (CCI) with the following assumptions, 253 firstly for age < 50 we assigned score of 0, age >= 50 (1), age < 60 ~ 1, age < 70 ~ 2, age 254 < 80 ~ 3, age >= 80 ~ 4. Similarly, for autoimmune, obesity, CHF, HTN, ASCVD, 255 COPD, asthma, ILD, OSA, the availability of events was scored "1" else "0". For CKD, 256 past cancer, transplant availability of event was score "2" else "0". Further, for Active 257 cancer availability of event was scored "6" else "0", followed by DM where availability 258 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint of event was scored "3" else "0". We used the r package "comorbidity" to calculate CCI 259 and "ggplot2" to plot CCI.

In the context of remote hospitals, patients and potential outcomes were distributed in a 262 manner that led to some of the most critical outcomes for COVID 19. The patient 263 characteristics are outlined in (Figure 2) . Table 2 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. Our cohort consisted of 38 records. There were no exclusion criteria applied, resulting in 289 38 records being included in the primary analysis (Supplement Table 1 The data collected over the span of two weeks from a remote hospital setting led to 303 critical observations. We calculated interquartile range (IQR) median values for the 304 variables. Thus, all discussion further will be IQR median. As demonstrated in (Table 1 ) 305 in 38 patients, the median age is 76. It is essential to note that our population of patients 306 is distributed as follows: Unvaccinated: 31 (82%), Unknown and Vaccinated are 2 (5.3%) 307 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. Earlier, we talked about how the more extensive cohort study analysis can facilitate the 322 potential biomarkers for the worst outcome in COVID 19. Figure 1 gender, BMI, and vaccination status ( Figure 1 ). As shown in (Figure 1) , BMI is 331 relatively higher in unvaccinated male patients. For the sake of simplicity in the study, we 332 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint avoided conclusions for the unknown vaccinated group due to their singleton number.

The male gender was also associated with higher mortality in earlier studies 26 . Therefore, Figure 3(a) . 343 Further, due to our small sample size, we also looked into the conservative approach of (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint have shown that weight (kilograms), BMI, and CRP levels are predictors of mortality in 359 severe COVID 19 cases. It has been documented that severe COVID 19 is associated 360 with higher inflammatory mediators due to cytokine storms. These markers may allow 361 early identification or even prediction of disease progression and define admission 362 priority 28. CRP is also known as an active regulator for innate immunity and predictor for Table 1, and Table 2 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint variables that may not be statistically significant due to the small sample size is also 385 depicted in Figure 3 (C) . As such, in Figure 3 404 We calculated the Charlson Comorbidity Index (CCI) 34 to identify the pattern of mortality 405 and contributing factors that may be causing the higher levels of inflammation.

According to (Figure S5) , the distribution of CCI across all comorbidities in our cohort 407 clearly illustrates that most patients fall into the high-risk group with higher age, BMI, 408 and obesity. Additionally, hypertension and diabetes are prevalent, indicates that 409 metabolic pathways played a significant role in mortality. Numerous studies have 410 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. for each patient, as shown in (Figure S6) . Keeping the CCI score zero as a baseline, it is 415 evident that any score in the range of three is prognostically indicative of death or poor 416 outcome in COVID 19 patients. An increase of one point above this will result in an 417 increase of 16% in mortality. (Figure s6 ) depicts that most of our patients had CCI > 3, 418 which indicates that most of these patients were considered high risk. M2 and M16 with 419 higher CCI were unvaccinated, while M36 with the lowest CCI was vaccinated. Even the 420 lowest CCI patient was >3, meaning that this patient was in a higher-risk group with 421 obvious signs on imaging and hypoxemia on presentation (SpO2 of 80% on room air). (Table 2) . Whites (Male) were overrepresented among all patients 436 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. SpO2 on arrival) have a higher predictive capability of mortality. 450 We have conducted a single-center and remotely located hospital's retrospective cohort 451 analysis of deceased COVID 19 patients. We started teasing out the data from an 452 observational perspective, as displayed in (Table 1) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint This study mirrored the findings of similarly conducted studies that showed associations 487 between the risk of in-hospital death, demographic factors (age, BMI), clinical factors 488 (D-dimer, CRP) as well as other biomarkers (as per Figure 1(a) ). For example, in a meta- ventilation is excellent. Moreover, this information has also concluded that inflammation-500 induced cytokine storm is associated with coagulopathy in COVID 19 infected patients.

Early rise in D-dimer suggests that coagulopathy acts as a prodrome of cytokine 502 Nonetheless, it was challenging to see any direct effects of treatment, we followed the 503 standard treatment protocols as described in a variety of exciting articles 43 , and our 504 observations can be seen in ( Figure S4 ). In terms of treatment, the mean hospital stay 505 was 11.4 (M) and 9.8 (F) days, respectively. Most commonly prescribed medications 506 were dexamethasone (n=37), remdesivir (n=35), enoxaparin/UFH (n=35) and tocilizumab 507 (n=5). As indicated in (Figure S4) , 20 patients required mechanical ventilation, 27 508 required non-invasive ventilation, and 26 required high-flow oxygen through nasal 509 cannulas. According to our data in Table 1 and Table 2 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. It was observed in our study cohort, patients with severe hypoxemic respiratory failure 537 reported increased length of stay prior to the need for mechanical ventilation. While this 538 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint may not explain all the parameters linked to increased COVID 19 severity, it may 539 contribute to some findings. Furthermore, our study is the largest to date for unvaccinated 540 patients in remote settings and uses machine learning to demonstrate that inflammation 541 affects COVID 19 severity, the sample size was insufficient to determine the independent 542 effects of specific treatments. Future efforts should be aimed at performing such analyses. In the wake of COVID 19, healthcare workers felt the brunt of it. Often this impact is 559 multidimensional, encompassing factors like work management, mental health, and social 560 needs. Another factor contributing to the prevalence of these issues is the disparity 561 between medical centers in urban and rural areas. For example, the pandemic had twice 562 the mortality rate in remote centers than in urban centers 44 . In addition, a large number of 563 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Even with these obstacles, the hospital administration endeavors to provide up-to-date 583 health care for their community members. In addition, the advent of telemedicine has 584 enabled urban and rural areas to stay closely connected during this pandemic period. 585 However, the fact remains that many possibilities remain unexplored and yet to be 586 implemented to continue catering quality medical care throughout the country. 587 Imputation Impact: 588 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. ; https://doi.org/10.1101/2022.01.04.21267659 doi: medRxiv preprint

We imputed clinical variables with a K-NN algorithm to fix the missing data issue; 589 although theoretically, it was more sensitive and specific, the actual values could be 590 different based on clinical representation, treatment, and other prognostic variables. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. Table S1 : Logistic regression to classify the vaccination status. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 5, 2022. The data can be retrieved using the guidelines set forth by Mercy medical center. 

Changes Over Time in COVID-19 Severity and Mortality 654 in Patients Undergoing Cancer Treatment in the United States: Initial Report 655 From the ASCO Registry

COVID-19 Vaccination and Non-COVID-19 Mortality Risk -Seven 658

Integrated Health Care Organizations, United States

Endothelial activation and dysfunction in COVID-19: from basic 661 mechanisms to potential therapeutic approaches

COVID vaccines cut the risk of transmitting Delta -but not for 664 long

Community COVID-19 Incidence and Health Care 666

D-dimer as a biomarker for disease severity and mortality in 668 COVID-19 patients: a case control study

COVID-19): systematic review and meta-analysis

Hypothesis for potential pathogenesis of 673 SARS-CoV-2 infection-a review of immune changes in patients with viral 674 pneumonia

High expression of ACE2 receptor of 2019-nCoV on the epithelial 676 cells of oral mucosa

Lymphopenia predicts disease severity of COVID-19: a 678 descriptive and predictive study

Predictive Biomarkers of Intensive Care Unit and Mechanical 680 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

A multi-mechanism approach reduces length of stay in 683 the ICU for severe COVID-19 patients

Prognostic Value of Inflammatory Biomarkers in Patients with Severe 685 COVID-19: A Single-Center Retrospective Study -Gönül Açıksarı

Lütfiye Nilsun Altunal, Adem Atıcı, Fatma Betül Çelik

Novel serological biomarkers for inflammation in predicting 690 disease severity in patients with COVID-19

Six-Month Outcomes in COVID-19 ICU Patients 693 and Their Family Members: A Prospective Cohort Study. Healthcare (Basel) 9

Quality of life of COVID-19 critically ill survivors after 696 ICU discharge: 90 days follow-up

Cigarette Smoking and COVID-19: A Complex Interaction

Obesity and Hypertension in the Time of 701 COVID-19

Comorbidity and its Impact on Patients with COVID-19

Prognostic value of lymphocyte count in severe COVID-19 705 patients with corticosteroid treatment

Level and Neutrophils Count as Predictive and 707 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Post-anticoagulant D-dimer is a highly prognostic biomarker 710 of COVID-19 mortality

Prevalence and Outcomes of D-Dimer Elevation in 712 Hospitalized Patients With COVID-19. Arteriosclerosis, Thrombosis, and 713

Initial observations on age, gender, BMI and hypertension in 715 antibody responses to SARS-CoV-2 BNT162b2 vaccine

Douglas County Health Department -Health Impact Assessments

Male gender is a predictor of higher mortality in 721 hospitalized adults with COVID-19

Impact of age and gender on lymphocyte subset counts in 723 patients with COVID-19

Update Advances on C-Reactive Protein in 725 COVID-19 and Other Viral Infections

D-dimer 728 and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary 729 Embolism in Two COVID-19 Patients

Course of D-Dimer and C-Reactive Protein Levels in 732 Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective 733 Analysis of 577 Patients

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Time course of procoagulant activity and D dimer in 738 bronchoalveolar fluid of patients at risk for or with acute respiratory distress 739 syndrome

PaO2/FIO2 ratio: the mismeasure of 741 oxygenation in COVID-19

SARS CoV 2 virus infection and A novel COVID 19 mortality index

Online Library

Association of Patient Characteristics

Diabetes, Obesity, COVID-19, Insulin, and 753 Other Antidiabetes Drugs

Covid-19: Unvaccinated face 11 times risk of death from delta 755 variant, CDC data show

COVID-19 hospital admissions and deaths after 757 BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in

EAVE II): a prospective cohort study. The Lancet Respiratory 759 Medicine 0

& 761 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Human C-reactive protein induces endothelial dysfunction 764 and uncoupling of eNOS in vivo

Association of inflammatory markers with the severity of 766 COVID-19: A meta-analysis

Trends and diagnostic value of D-dimer levels in 768 patients hospitalized with coronavirus disease 2019

Interventions for treatment of COVID-19: a protocol for a 771 living systematic review with network meta-analysis including individual patient 772 data (The LIVING Project)

Urban-rural differences in COVID-19 exposures and 774 outcomes in the South: A preliminary analysis of South Carolina

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

The authors are profoundly grateful for dedicating this research to all the patients and